RAG1/2 re-expression causes receptor revision in a model B cell line

Molecular Immunology

Volumn 44, Issue 5, 2007, Pages 889-899

  Da Sylva, Tanya R ^a   Fong, Ivan C ^b   Cunningham, Lesley A ^a   Wu, Gillian E ^a  

^a YORK UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

B lymphocytes; Gene rearrangement; RAG1 2 re expression; Repertoire development

Indexed keywords

BUTYRATE RESPONSE FACTOR 1; CARRIER PROTEIN; CD45 ANTIGEN; FIBRONECTIN; HIGH MOBILITY GROUP B2 PROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; PROTEIN DNAPK; PROTEIN LYSINE 6 OXIDASE; PROTEIN TAP2; RAG1 PROTEIN; RAG2 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNITY; B CELL LYMPHOMA; B LYMPHOCYTE; CELL CULTURE; CELL MATURATION; CONTROLLED STUDY; DOWN REGULATION; GENE DELETION; GENE EXPRESSION PROFILING; GENE REARRANGEMENT; GENE REPRESSION; HUMAN; HUMAN CELL; MALE; MICROARRAY ANALYSIS; MOLECULAR DYNAMICS; MOLECULAR MODEL; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; B-LYMPHOCYTES; CELL LINE, TUMOR; DNA-BINDING PROTEINS; GENE EXPRESSION PROFILING; GENE REARRANGEMENT, B-LYMPHOCYTE; HOMEODOMAIN PROTEINS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN LAMBDA-CHAINS; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA; TRANSFECTION;

EID: 33748874286     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2006.03.022     Document Type: Article

References (46)

1. Dolhain R.J., Tak P.P., Dijkmans B.A., De Kuiper P., Breedveld F.C., and Miltenburg A.M. Methotrexate reduces inflammatory cell numbers, expression of monokines and of adhesion molecules in synovial tissue of patients with rheumatoid arthritis. Br. J. Rheumatol. 37 (1998) 502-508
2. DuBois R.N., McLane M.W., Ryder K., Lau L.F., and Nathans D. A growth factor-inducible nuclear protein with a novel cysteine/histidine repetitive sequence. J. Biol. Chem. 265 (1990) 19185-19191
3. Durdik J., Moore M.W., and Selsing E. Novel kappa light-chain gene rearrangements in mouse lambda light chain-producing B lymphocytes. Nature 307 (1984) 749-752
4. Engel H., Rolink A., and Weiss S. B cells are programmed to activate kappa and lambda for rearrangement at consecutive developmental stages. Eur. J. Immunol. 29 (1999) 2167-2176
5. Erikson J., Radic M.Z., Camper S.A., Hardy R.R., Carmack C., and Weigert M. Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice. Nature 349 (1991) 331-334
6. Gartner F., Alt F.W., Monroe R.J., and Seidl K.J. Antigen-independent appearance of recombination activating gene (RAG)-positive bone marrow B cells in the spleens of immunized mice. J. Exp. Med. 192 (2000) 1745-1754
7. Gay D., Saunders T., Camper S., and Weigert M. Receptor editing: an approach by autoreactive B cells to escape tolerance. J. Exp. Med. 177 (1993) 999-1008
8. Girschick H.J., Grammer A.C., Nanki T., Mayo M., and Lipsky P.E. RAG1 and RAG2 expression by B cell subsets from human tonsil and peripheral blood. J. Immunol. 166 (2001) 377-386
9. Girschick H.J., Grammer A.C., Nanki T., Vazquez E., and Lipsky P.E. Expression of recombination activating genes 1 and 2 in peripheral B cells of patients with systemic lupus erythematosus. Arthritis Rheum. 46 (2002) 1255-1263
10. Grawunder U., Leu T.M., Schatz D.G., Werner A., Rolink A.G., Melchers F., and Winkler T.H. Down-regulation of RAG1 and RAG2 gene expression in preB cells after functional immunoglobulin heavy chain rearrangement. Immunity 3 (1995) 601-608
11. Han S., Dillon S.R., Zheng B., Shimoda M., Schlissel M.S., and Kelsoe G. V(D)J recombinase activity in a subset of germinal center B lymphocytes. Science 278 (1997) 301-305
12. Han S., Zheng B., Schatz D.G., Spanopoulou E., and Kelsoe G. Neoteny in lymphocytes: Rag1 and Rag2 expression in germinal center B cells. Science 274 (1996) 2094-2097
13. Herschman H.R. Extracellular signals, transcriptional responses and cellular specificity. Trends Biochem. Sci. 14 (1989) 455-458
14. Hikida M., Mori M., Takai T., Tomochika K., Hamatani K., and Ohmori H. Reexpression of RAG-1 and RAG-2 genes in activated mature mouse B cells. Science 274 (1996) 2092-2094
15. Igarashi H., Kuwata N., Kiyota K., Sumita K., Suda T., Ono S., Bauer S.R., and Sakaguchi N. Localization of recombination activating gene 1/green fluorescent protein (RAG1/GFP) expression in secondary lymphoid organs after immunization with T-dependent antigens in rag1/gfp knockin mice. Blood 97 (2001) 2680-2687
16. Kawakami K., Kita K., Miwa H., Ikeda T., Nishii K., Masuya M., Morita N., Ohno T., Tanaka I., Nosaka T., et al. Rearrangement patterns of immunoglobulin heavy chain (IgH) and light chain genes in acute lymphoblastic leukemia and chronic myelocytic leukemia lymphoid crisis cells showing oligoclonal IgH gene rearrangements. Int. J. Hematol. 55 (1992) 61-69
17. Kobayashi T., Okada F., Fujii N., Tomita N., Ito S., Tazawa H., Aoyama T., Choi S.K., Shibata T., Fujita H., and Hosokawa M. Thymosin-beta4 regulates motility and metastasis of malignant mouse fibrosarcoma cells. Am. J. Pathol. 160 (2002) 869-882
18. Lantelme E., Palermo B., Granziero L., Mantovani S., Campanelli R., Monafo V., Lanzavecchia A., and Giachino C. Cutting edge: recombinase-activating gene expression and V(D)J recombination in CD4+CD3low mature T lymphocytes. J. Immunol. 164 (2000) 3455-3459
19. Leu T.M., and Schatz D.G. Rag-1 and rag-2 are components of a high-molecular-weight complex, and association of rag-2 with this complex is rag-1 dependent. Mol. Cell. Biol. 15 (1995) 5657-5670
20. Lieber M.R., Hesse J.E., Lewis S., Bosma G.C., Rosenberg N., Mizuuchi K., Bosma M.J., and Gellert M. The defect in murine severe combined immune deficiency: joining of signal sequences but not coding segments in V(D)J recombination. Cell 55 (1988) 7-16
21. Ma Q., and Herschman H.R. A corrected sequence for the predicted protein from the mitogen-inducible TIS11 primary response gene. Oncogene 6 (1991) 1277-1278
22. Ma Y., Pannicke U., Schwarz K., and Lieber M.R. Hairpin opening and overhang processing by an Artemis/DNA-dependent protein kinase complex in nonhomologous end joining and V(D)J recombination. Cell 108 (2002) 781-794
23. Monroe R.J., Seidl K.J., Gaertner F., Han S., Chen F., Sekiguchi J., Wang J., Ferrini R., Davidson L., Kelsoe G., and Alt F.W. RAG2:GFP knockin mice reveal novel aspects of RAG2 expression in primary and peripheral lymphoid tissues. Immunity 11 (1999) 201-212
24. Morel L., Mohan C., Yu Y., Croker B.P., Tian N., Deng A., and Wakeland E.K. Functional dissection of systemic lupus erythematosus using congenic mouse strains. J. Immunol. 158 (1997) 6019-6028
25. Muller B., Stappert H., and Reth M. A physical map and analysis of the murine C kappa-RS region show the presence of a conserved element. Eur. J. Immunol. 20 (1990) 1409-1411
26. Nagafuchi H., Yoshikawa H., Takeba Y., Nara K., Miura K., Kurokawa M.S., and Suzuki N. Recombination activating genes (RAG) induce secondary Ig gene rearrangement in and subsequent apoptosis of human peripheral blood circulating B lymphocytes. Clin. Exp. Immunol. 136 (2004) 76-84
27. Oettinger M.A., Schatz D.G., Gorka C., and Baltimore D. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science 248 (1990) 1517-1523
28. Papavasiliou F., Casellas R., Suh H., Qin X.F., Besmer E., Pelanda R., Nemazee D., Rajewsky K., and Nussenzweig M.C. V(D)J recombination in mature B cells: a mechanism for altering antibody responses. Science 278 (1997) 298-301
29. Pearce R.B., Trigler L., Svaasand E.K., Chen H.M., and Peterson C.M. Levels of Tap-1 and Tap-2 mRNA and expression of Kd and Db on splenic lymphocytes are normal in NOD mice. Diabetes 44 (1995) 572-579
30. Pennycook J.L.M.H., Marshall A.J., and Wu G.E. PCR assays for endogenous Ig gene rearrangement. In: Lefkovits I. (Ed). Immunology Methods Manual: The comprehensive Sourcebook of Techniques vol. 1 (1997), Academic Press, San Diego, California 564
31. Reddy M.A., Kim Y.S., Lanting L., and Natarajan R. Reduced growth factor responses in vascular smooth muscle cells derived from 12/15-lipoxygenase-deficient mice. Hypertension 41 (2003) 1294-1300
32. Retter M.W., and Nemazee D. Receptor editing occurs frequently during normal B cell development. J. Exp. Med. 188 (1998) 1231-1238
33. Rice J.S., Newman J., Wang C., Michael D.J., and Diamond B. Receptor editing in peripheral B cell tolerance. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 1608-1613
34. Romberger D.J. Fibronectin. Int. J. Biochem. Cell. Biol. 29 (1997) 939-943
35. Schatz D.G., Oettinger M.A., and Baltimore D. The V(D)J recombination activating gene, RAG-1. Cell 59 (1989) 1035-1048
36. Schmitt L., and Tampe R. Affinity, specificity, diversity: a challenge for the ABC transporter TAP in cellular immunity. Chembiochem 1 (2000) 16-35
37. Shimada H., Ichikawa H., Nakamura S., Katsu R., Iwasa M., Kitabayashi I., and Ohki M. Analysis of genes under the downstream control of the t(8;21) fusion protein AML1-MTG8: overexpression of the TIS11b (ERF-1, cMG1) gene induces myeloid cell proliferation in response to G-CSF. Blood 96 (2000) 655-663
38. Shimizu T., Iwasato T., and Yamagishi H. Deletions of immunoglobulin C kappa region characterized by the circular excision products in mouse splenocytes. J. Exp. Med. 173 (1991) 1065-1072
39. Siminovitch K.A., Moore M.W., Durdik J., and Selsing E. The human kappa deleting element and the mouse recombining segment share DNA sequence homology. Nucleic Acids Res. 15 (1987) 2699-2705
40. Smith-Mungo L.I., and Kagan H.M. Lysyl oxidase: properties, regulation and multiple functions in biology. Matrix Biol. 16 (1998) 387-398
41. Stoecklin G., Gross B., Ming X.F., and Moroni C. A novel mechanism of tumor suppression by destabilizing AU-rich growth factor mRNA. Oncogene 22 (2003) 3554-3561
42. van Gent D.C., Hiom K., Paull T.T., and Gellert M. Stimulation of V(D)J cleavage by high mobility group proteins. EMBO J. 16 (1997) 2665-2670
43. Varnum B.C., Ma Q.F., Chi T.H., Fletcher B., and Herschman H.R. The TIS11 primary response gene is a member of a gene family that encodes proteins with a highly conserved sequence containing an unusual Cys-His repeat. Mol. Cell. Biol. 11 (1991) 1754-1758
44. Wakui M., Kim J., Butfiloski E.J., Morel L., and Sobel E.S. Genetic dissection of lupus pathogenesis: Sle3/5 impacts IgH CDR3 sequences, somatic mutations, and receptor editing. J. Immunol. 173 (2004) 7368-7376
45. Wilson A., Held W., and MacDonald H.R. Two waves of recombinase gene expression in developing thymocytes. J. Exp. Med. 179 (1994) 1355-1360
46. Yu W., Nagaoka H., Jankovic M., Misulovin Z., Suh H., Rolink A., Melchers F., Meffre E., and Nussenzweig M.C. Continued RAG expression in late stages of B cell development and no apparent re-induction after immunization. Nature 400 (1999) 682-687